Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone. (Q44965024)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 July 2004
edit
Language Label Description Also known as
English
Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone.
scientific article published on 3 July 2004

    Statements

    Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit